Table 1.
Studies of patients with breast cancer and Iscador therapy in matched-pair design
| Design | Study | Indication | Pairs of patients | Published | |||||
|---|---|---|---|---|---|---|---|---|---|
| Recruited | Therapy declined or not received | Drop-out after start of therapy | Lost to follow-up | Matching criteria not fulfilled | Final | ||||
| Randomized matched-pairs | MammaRand | Breast cancer without recurrences or metastases | 59 | 19 | 0 | 2 | 5 | 38 | (8) |
| MammaLymRand | Breast cancer with lymphatic metastases | 17 | 0 | 0 | 0 | 0 | 17 | (6,9) | |
| MAMMARAND | Breast cancer | 76 | 19 | 0 | 2 | 5 | 55 | ||
| Non-randomized matched-pairs | Mamma | Breast cancer without recurrences or metastases | 105 | 2 | 0 | 6 | 13 | 84 | (8) |
| MammaRec | Breast cancer with only local recurrences | 50 | 5 | 0 | 2 | 1 | 42 | (6,9) | |
| MammaLym | Breast cancer with lymphatic metastases | 64 | 7 | 0 | 1 | 1 | 55 | (6,9) | |
| MammaMet | Breast cancer with distant metastases | 90 | 2 | 0 | 3 | 2 | 83 | (6,9) | |
| MAMMA | Breast cancer | 309 | 16 | 0 | 12 | 17 | 264 | ||